Liver

Dr. Tanios Bekaii-Saab, MD FACP Professor of Gastrointestinal Cancer Mayo Clinic College of Medicine and Science.

Immunotherapy combined with anti VEGF is new standard treatment for Liver Cancer based on IMbrave150 clinical study

Cabometyx™ standard second line treatment for Liver Cancer.

Incidence of Liver Cancer on the Rise

TACE is an effective treatment for liver cancer and appears to be improved when combined with RFA or systemic therapy.

Precision cancer medicines begin redefine treatment of cholangiocarcinoma. FGFR inhibitor Pemazyre is now FDA approved.

Opdivo Precision Cancer Medicine with or without Yervoy Improves Outcomes in Advanced Liver Cancer